UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Crohn Disease: Epidemiology, Diagnosis, and Management

Mayo Clinic proceedings, 2017-07, Vol.92 (7), p.1088-1103

2017

Volltextzugriff (PDF)

Management of active Crohn disease

JAMA : the journal of the American Medical Association, 2013-05, Vol.309 (20), p.2150

Cheifetz, Adam S

2013

Volltextzugriff (PDF)

Ulcerative colitis: epidemiology, diagnosis, and management

Mayo Clinic proceedings, 2014-11, Vol.89 (11), p.1553-1563

2014

Volltextzugriff (PDF)

Etiology and Management of Lack or Loss of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease

Gastroenterology & hepatology, 2019-12, Vol.15 (12), p.656-665

2019

Volltextzugriff (PDF)

Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy

The American journal of gastroenterology, 2017-05, Vol.112 (5), p.673-676

2017

Volltextzugriff (PDF)

PUCCINI: Safety of Anti-TNF in the Perioperative Setting

Gastroenterology (New York, N.Y. 1943), 2022-07, Vol.163 (1), p.44-46

2022

Volltextzugriff (PDF)

Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases

Gastroenterology (New York, N.Y. 1943), 2017-02, Vol.152 (2), p.415-429.e15

2017

Volltextzugriff (PDF)

Therapeutic drug monitoring in inflammatory bowel disease: for every patient and every drug?

Current opinion in gastroenterology, 2019-07, Vol.35 (4), p.302-310

2019

Volltextzugriff (PDF)

Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis

The American journal of gastroenterology, 2013-01, Vol.108 (1), p.40-47

2013

Volltextzugriff (PDF)

Therapeutic drug monitoring in patients on biologics: lessons from gastroenterology

Current opinion in rheumatology, 2020-07, Vol.32 (4), p.371-379

2020

Volltextzugriff (PDF)

A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

The American journal of gastroenterology, 2021-10, Vol.116 (10), p.2014-2025

2021

Volltextzugriff (PDF)

Editorial: is there a role for monitoring intermediate anti‐TNF drug concentrations in IBD?

Alimentary pharmacology & therapeutics, 2022-04, Vol.55 (8), p.1049-1050

2022

Volltextzugriff (PDF)

Review article: emerging drug therapies in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2022-04, Vol.55 (7), p.789-804

2022

Volltextzugriff (PDF)

Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies

Clinical immunology (Orlando, Fla.), 2019-09, Vol.206, p.9-14

2019

Volltextzugriff (PDF)

Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease

Digestive diseases and sciences, 2018-11, Vol.63 (11), p.3067-3073

2018

Volltextzugriff (PDF)

Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease

Alimentary pharmacology & therapeutics, 2021-10, Vol.54 (8), p.1085-1086

2021

Volltextzugriff (PDF)

Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

Clinical gastroenterology and hepatology, 2021-04, Vol.19 (4), p.854-855

2021

Volltextzugriff (PDF)

Improved Long-Term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab

Clinical gastroenterology and hepatology, 2017-10, Vol.15 (10), p.1580-1588.e3

2017

Volltextzugriff (PDF)

Association Between Serum Infliximab Trough Concentrations During Maintenance Therapy and Biochemical, Endoscopic, and Histologic Remission in Crohn's Disease

Inflammatory bowel diseases, 2018-09, Vol.24 (10), p.2266-2271

2018

Volltextzugriff (PDF)

Risankizumab Concentration but not IL-22 Levels are Associated With Clinical and Biochemical Remission in Patients With Crohn’s Disease

Clinical gastroenterology and hepatology, 2024-05

2024

Volltextzugriff (PDF)

Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2023-01, Vol.164 (1), p.164-165

2023

Volltextzugriff (PDF)

Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer

Gastrointestinal endoscopy, 2019-08, Vol.90 (2), p.186-195.e1

2019

Volltextzugriff (PDF)

Optimizing therapeutic drug monitoring in inflammatory bowel disease: a focus on therapeutic monoclonal antibodies

Expert opinion on drug metabolism & toxicology, 2021-12, Vol.17 (12), p.1423-1431

2021

Volltextzugriff (PDF)

Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window

Inflammatory bowel diseases, 2017-09, Vol.23 (9), p.1510-1515

2017

Volltextzugriff (PDF)

Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease

Inflammatory bowel diseases, 2013-01, Vol.19 (1), p.15-22

2013

Volltextzugriff (PDF)

1 – 25 von 462

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(399)
Mit Volltextzugriff
(371)

Publikationsform

Artikel
(403)
Buchkapitel
(54)
Bücher
(3)
Berichte
(2)

Sprache

Englisch
(462)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(214)
Life Sciences & Biomedicine
(211)
Humans
(181)
Gastroenterology & Hepatology
(151)
Inflammatory Bowel Disease
(94)
Female
(83)
Male
(82)
Ulcerative Colitis
(77)
Gastroenterology
(69)
Gastroenterology And Hepatology
(66)
Adult
(59)
Crohn's Disease
(51)
Middle Aged
(50)
Infliximab
(47)
Inflammatory Bowel Diseases - Drug Therapy
(42)
General & Internal Medicine
(38)
Crohn’s Disease
(34)
Child
(32)
Pediatrics
(30)
Crohn Disease - Drug Therapy
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Crohn Disease: Epidemiology, Diagnosis, and Management

Management of active Crohn disease

Ulcerative colitis: epidemiology, diagnosis, and management

Etiology and Management of Lack or Loss of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease

Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy

PUCCINI: Safety of Anti-TNF in the Perioperative Setting

Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases

Therapeutic drug monitoring in inflammatory bowel disease: for every patient and every drug?

Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis

Therapeutic drug monitoring in patients on biologics: lessons from gastroenterology

A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

Editorial: is there a role for monitoring intermediate anti‐TNF drug concentrations in IBD?

Review article: emerging drug therapies in inflammatory bowel disease

Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies

Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease

Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease

Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

Improved Long-Term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab

Association Between Serum Infliximab Trough Concentrations During Maintenance Therapy and Biochemical, Endoscopic, and Histologic Remission in Crohn's Disease

Risankizumab Concentration but not IL-22 Levels are Associated With Clinical and Biochemical Remission in Patients With Crohn’s Disease

Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn’s Disease

Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer

Optimizing therapeutic drug monitoring in inflammatory bowel disease: a focus on therapeutic monoclonal antibodies

Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window

Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease

Suchergebnisse filtern